Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4Q9D4
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0005515 | protein binding | 2 | 10 |
GO:0019905 | syntaxin binding | 4 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 183 | 187 | PF00656 | 0.287 |
CLV_C14_Caspase3-7 | 47 | 51 | PF00656 | 0.403 |
CLV_MEL_PAP_1 | 134 | 140 | PF00089 | 0.287 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.274 |
CLV_NRD_NRD_1 | 152 | 154 | PF00675 | 0.354 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.281 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.424 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.303 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.266 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.281 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.391 |
CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.366 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.463 |
CLV_PCSK_PC1ET2_1 | 304 | 306 | PF00082 | 0.281 |
CLV_PCSK_PC1ET2_1 | 76 | 78 | PF00082 | 0.391 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 291 | 295 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.331 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.287 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.641 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.598 |
DOC_USP7_MATH_1 | 324 | 328 | PF00917 | 0.309 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.640 |
LIG_14-3-3_CanoR_1 | 137 | 145 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 223 | 227 | PF00244 | 0.317 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.688 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.268 |
LIG_FHA_2 | 162 | 168 | PF00498 | 0.260 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.393 |
LIG_FHA_2 | 313 | 319 | PF00498 | 0.411 |
LIG_LIR_Gen_1 | 178 | 188 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 192 | 202 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.302 |
LIG_Pex14_2 | 177 | 181 | PF04695 | 0.360 |
LIG_SH2_SRC | 202 | 205 | PF00017 | 0.443 |
LIG_SH2_STAP1 | 240 | 244 | PF00017 | 0.373 |
LIG_SH2_STAT3 | 104 | 107 | PF00017 | 0.287 |
LIG_SH2_STAT3 | 240 | 243 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.331 |
LIG_SH3_3 | 248 | 254 | PF00018 | 0.331 |
LIG_SUMO_SIM_anti_2 | 208 | 213 | PF11976 | 0.398 |
LIG_TRAF2_1 | 201 | 204 | PF00917 | 0.411 |
LIG_TRAF2_1 | 327 | 330 | PF00917 | 0.576 |
LIG_TRAF2_1 | 9 | 12 | PF00917 | 0.570 |
LIG_TRAF2_1 | 97 | 100 | PF00917 | 0.366 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.461 |
MOD_CK2_1 | 161 | 167 | PF00069 | 0.308 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.242 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.393 |
MOD_CK2_1 | 312 | 318 | PF00069 | 0.419 |
MOD_CK2_1 | 324 | 330 | PF00069 | 0.742 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.667 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.649 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.364 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.648 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.393 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.571 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.633 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.335 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.404 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.639 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.314 |
MOD_NEK2_2 | 84 | 89 | PF00069 | 0.200 |
MOD_PKA_1 | 173 | 179 | PF00069 | 0.421 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.397 |
MOD_PKA_2 | 222 | 228 | PF00069 | 0.439 |
MOD_PKA_2 | 270 | 276 | PF00069 | 0.367 |
MOD_PKB_1 | 153 | 161 | PF00069 | 0.287 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.377 |
MOD_Plk_2-3 | 222 | 228 | PF00069 | 0.348 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.357 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.283 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.636 |
MOD_SUMO_for_1 | 252 | 255 | PF00179 | 0.343 |
MOD_SUMO_for_1 | 303 | 306 | PF00179 | 0.300 |
TRG_DiLeu_BaEn_1 | 194 | 199 | PF01217 | 0.287 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.386 |
TRG_ER_diArg_1 | 114 | 116 | PF00400 | 0.288 |
TRG_ER_diArg_1 | 219 | 221 | PF00400 | 0.309 |
TRG_NES_CRM1_1 | 70 | 82 | PF08389 | 0.331 |
TRG_NLS_Bipartite_1 | 65 | 79 | PF00514 | 0.269 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2W3 | Leptomonas seymouri | 65% | 99% |
A0A0S4JT11 | Bodo saltans | 31% | 90% |
A0A1X0NSF2 | Trypanosomatidae | 36% | 93% |
A0A3Q8IFN3 | Leishmania donovani | 92% | 100% |
A0A3R7M749 | Trypanosoma rangeli | 37% | 91% |
A4HER5 | Leishmania braziliensis | 82% | 100% |
A4I1Z2 | Leishmania infantum | 93% | 100% |
C9ZS22 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 91% |
E9AY39 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
V5BZC0 | Trypanosoma cruzi | 36% | 91% |